A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia
Clinical trial NCT07421297 · RECRUITING
Trial details
- NCT number
- NCT07421297
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-28
- Primary completion
- 2027-12-31
- Enrollment
- 760
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.